Alexion Pharmaceuticals Inc. Bottom Line Advances 20% In Q4
Thursday, 16 February 2017
WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals Inc. (ALXN) announced a profit for its fourth quarter that increased compared to the same period last year.The company said its bottom line totaled $...
Market News Video - ▶ 01:19
Recent related news
WASHINGTON COUNTY (dpa-AFX) - Nike Inc (NKE) revealed a profit for its third quarter that increased from last year.The company said its bottom line came in at...
3 days ago • FinanzNachrichten.de
With long-time investors dropping Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), questions remain: has the stock truly hit the bottom, and can it...
4 days ago • Motley Fool